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Abstract
Background: Acute necrotizing pancreatitis (ANP) is often complicated by multiple organ failure. The small
intestine is frequently damaged during ANP. Capillary leakage in multiple organs during ANP is one of the most
important causes of multiple organ dysfunction. Damage to the capillary endothelial barrier and impaired water
transportation could lead to capillary leakage in ANP.
Methods: Sprague–Dawley (SD) rats were randomized into a control group, the ANP group, the culture media-
treated group, or the bone marrow-derived mesenchymal stem cell (BMSC)-treated group (30 rats in each group).
Ten rats in each group were sacrificed at 6, 12, and 24 h after induction of experimental models. Serum, ascites,
pancreatic, and small intestinal samples were collected. The levels of serum and ascites albumin and amylases were
measured, pancreatic histology was assessed, and the connection changes between vessel endothelial cells were
evaluated using scanning electron microscopy (SEM). Capillary leakage in small intestinal tissue was observed
visually by tracking fluorescein isothiocyanate (FITC)-albumin, and was measured by the Evans blue extravasation
method. The location and expression of aquaporin 1 (AQP1) in the small intestine was analyzed using
immunohistochemistry, real-time polymerase chain reaction (PCR), and Western blot.
Results: The outcomes showed that the level of serum and ascites amylase is elevated. Conversely, the level of
serum albumin is decreased while ascites albumin is elevated. There is damage to pancreatic tissue, and the
small intestinal capillary endothelial barrier was aggravated. Furthermore, the expression of AQP1 was reduced
significantly after induced ANP. Following treatment with MSCs, the elevation of amylase and the decrease of
serum albumin were inhibited, the damage to pancreatic tissue and the level of small intestinal capillary leakage
was alleviated, and the downregulation of AQP1 was reversed.
Conclusions: In conclusion, MSC therapy could alleviate small intestinal injury in rats with ANP, the mechanism of
which might be related to reduction of damage to the small intestinal capillary endothelial barrier, and increased
expression of AQP1 in the small intestine.
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Background
Acute necrotizing pancreatitis (ANP) is a challenging dis-
ease with high morbidity and mortality, often complicated
by multiple organ failure. Two phases of ANP are ob-
served in the clinic: the early toxico-enzymatic phase and
the later septic phase [1]. Capillary leakage occurs in the
early phase of ANP. Capillary leakage in multiple organs
during ANP is one of the most important causes of
multiple organ dysfunction. The small intestine is fre-
quently damaged during ANP. Intestinal edema, abundant
amylase and bloody ascites, and intestinal barrier func-
tional disturbances can be found in ANP. The damage to
the capillary endothelial barrier and the function of water
transportation could lead to capillary leakage in ANP.
Aquaporins (AQPs) form the water channels that are
responsible for the water permeability of some biological
membranes [2]. AQP1 is the first member of the AQP
family to be identified in erythrocytes [3]. In the small
intestine, AQP1 is widely distributed on the capillary or
microvascular endothelium of lymphatic cells [4–7].
Studies show that the abnormality of AQP1 is a main
contributor to many diseases [2, 6]. The expression of
AQP1 is significantly reduced in a murine model of
lipopolysaccharide (LPS)-induced acute lung injury [8],
and in the pancreas, lung, and intestinal tissue of rats
with ANP [9].
Mesenchymal stem cells (MSCs) have the capability to
regulate the immune system and regenerate damaged
tissue, making them good candidates for cell-based
therapy [10–13]. MSCs reduced inflammation and
damage to pancreatic tissue in a rat model of acute pan-
creatitis [14]. MSC treatment could increase the speed
of recovery and restore function to the small intestine in
a mouse model of radiation-induced gastrointestinal
tract damage [15]. MSCs could reduce vascular endothe-
lium injury, and decrease endothelial permeability in-
duced by LPS [16]. Whether MSCs have protective
effects in small intestinal capillary leakage in ANP has
not yet been studied.
In this study, we examined the changes of the small in-
testinal capillary endothelial barrier and AQP1 expression
in the rat model of ANP, and explored whether MSCs
have a protective effect on small intestinal injury induced
by ANP through their impact on the capillary endothelial
barrier and expression of AQP1 in the small intestine.
Methods
Ethics
All animal experimental procedures were approved by
the Experimental Animals Committee of Fujian Medical
University. All animals received humane care in compli-
ance with the Guide for the Care and Use of Laboratory
Animals (NIH publication No.85-23, National Academy
Press, Washington, DC, USA, revised 1996).
Experimental animals and grouping
Clean adult male Sprague–Dawley (SD) rats, weight
200–250 g, were provided by Shanghai SLAC Laboratory
Animal Co. Ltd., and adaptively fed for a week in a room
with temperature maintained at 20 ± 2 °C. Experimental
animals were treated according to ethical guidelines and
standards. Rats (n = 120) were randomly divided into a
control group, culture media-treated group, ANP group,
and MSC-treated group (n = 30 per group). Observations
were made at three time points (6 h, 12 h, and 24 h; n =
10 for each) and the rats were sacrificed at each time
point for sample collection.
Culture, identification, and labeling of MSCs
MSCs were isolated from the bone marrow of 1-month-
old male SD rats by the differential adherence method
[17–19]. In brief, the tibia and femur of SD rats were
separated under sterile conditions to expose the bone
marrow cavity which was flushed with Dulbecco’s
modified Eagle’s medium (DMEM; GE Healthcare Life
Sciences, Logan, UT, USA) culture media. The bone
marrow filtrate was collected and centrifuged (1500 rpm,
3 min). The cells were resuspended in DMEM supple-
mented with 10% fetal calf serum (FCS) and 1% penicillin/
streptomycin, and then inoculated in a 25-mL culture
flask at the concentration of 5 × 107/mL and incubated at
37 °C and 5% CO2. Two days after plating, the dishes were
washed three times with 10% FCS-DMEM to remove
non-adherent hematopoietic cells. Subsequently, the
medium was changed every 2–3 days and cells were main-
tained until reaching 80–90% confluence. Confluent cells
were dissociated using EDTA-Trypsin (Invitrogen, San
Diego, CA, USA). They were cultured for multiple genera-
tions and purified by dissociation. MSCs in the third gen-
eration were acquired for further experiments. Expression
of surface markers CD29, CD45, CD90 (Biolegend, San
Diego, CA, USA), and CD34 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) on MSCs was confirmed by flow
cytometry analysis (FACS; Canto, Becton Dickinson, San
Jose, CA, USA). MSCs were labeled using the cell tracker
CM-Dil (Molecular Probes Inc., USA) according to the
manufacturer’s instructions. MSCs in the third generation
with a concentration of 1 × 106 cells/mL were cultured in
5 μL CM-Dil labeling solution (2 mg CM-Dil/mL).
CM-Dil cell suspensions were incubated for 5 min at 37 °C
and then for 15 min at 4 °C. After labeling, cells were
washed two times with phosphate-buffered saline
(PBS) at 1000 rpm for 5 min at 25 °C and resuspended in
fresh medium.
Establishment of the ANP animal model
The method used to create the rat model of ANP was as
described in previous studies [20–22]. Rats were fasted
for 12 h before the experiments, but allowed free access
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to water. After anesthesia with 10% chloral hydrate
(0.3 mL/100 g body weight; Bio Basic, Markham, ON,
Canada), an incision was made in the abdominal midline
under aseptic conditions. The bile duct near the portal
vein was clipped with a small bulldog clamp. Using a
surgical microscope (magnification 10×), a polyethylene
catheter (0.45 mm in diameter) was inserted into the
biliopancreatic duct where it enters the duodenum, and
was also clipped with a small bulldog clamp. Then 5%
sodium taurocholate solution (0.1 mL/100 g body
weight; Inalco Spa, Milano, Italy) was injected into the
biliopancreatic duct at a uniform speed of 0.04 mL/min
with a microinfusion pump, and the small bulldog clamp
was removed 10 min later. The duodenum was replaced
and the abdomen was closed. For rats in the control
group, the abdomen was closed after the pancreas and
duodenum were maneuvered as they were with the ANP
model. Following surgery, the rats were restricted from
water and food intake and normal saline was given via
subcutaneous injection in the back (4 mL/100 g body
weight; every 6 h).
Treatment with MSCs
Previous studies showed that MSCs transplanted via tail
vein injection might reside in the small intestine,
limiting gastrointestinal tract damage [15, 23, 24]. ANP-
induced animals were injected with 1 mL of MSCs
(about 1 × 106/mL) via the tail vein at 0 h, and sacrificed
at 6 h for the MSC-treated group 6-h time point. ANP-
induced animals were injected with 1 mL of MSCs
(about 1 × 106/mL) via the tail vein at 0 h and 6 h, and
sacrificed at 12 h for the MSC-treated group 12-h time
point. ANP-induced animals were injected with 1 mL of
MSCs (about 1 × 106/mL) via the tail vein at 0 h, 6 h,
and 12 h, and sacrificed at 24 h for the MSC-treated
group 24-h time point. The 0 h means the moment
when the abdomen was closed. The rats of the control
group and ANP group were injected with 1 mL normal
saline via the tail vein at the same time points as the
MSC-treated group. The rats in the culture media-
treated group were injected with 1 mL of culture media
(DMEM supplemented with 10% FCS and 1% penicillin/
streptomycin) via the tail vein at the same time points as
the MSC-treated group. After treatment with MSCs,
small intestine samples were collected at each time
point. Frozen small intestinal samples were cut into 10-μm
sections and observed under a confocal microscope (TCS
SP5, Leica, Germany) and pictures were taken.
Biochemical tests of blood and ascites
At each time point, blood and ascites samples were
collected and measured. They were centrifuged at
3000 rpm at 5 °C for 10 min. The serum and super-
natant of ascites were collected and stored at −80 °C
until analyzed. Amylase and albumin levels in serum and
ascitic fluid were analyzed using an automatic biochemical
detection instrument (LX20; Beckman Inc., USA).
Small intestine capillary leakage measurement using the
Evans blue method
To evaluate small intestinal capillary leakage we
prepared another nine groups of experimental animals
following the same experimental procedures previously
described [25–27]. Thirty minutes before the rats were
sacrificed, 5% Evans blue (20 mg/kg body weight) was
injected into the femoral vein. Thirty minutes later, the
chest was accessed through the diaphragm, a catheter
was put into the left ventricle, and the right atrium was
opened. Cold PBS was perfused into the heart with the
infusion apparatus under 40 cm water column pressure
until the fluid coming out of the right atrium became
clear. Next, 300 mg of tissue from the intestine was in-
cubated in 1 mL formaldehyde and homogenized with
an ultrasonic cell disruption device. Another 3 mL of
formaldehyde was added for preservation. After being
maintained in a 37 °C incubator for 48 h, the samples were
centrifuged (1000 rpm, 5 min) and supernatant was ana-
lyzed at 620 nm and 740 nm in a spectrophotometer (GE
Ultrospec 3100 pro, Amersham Biosciences, USA). The
correction formula is: E620corrected = E620 – (1.426 × E740
+ 0.030). After the Evans blue standard curve was drawn,
concentrations of Evans blue in the intestinal tissue were
calculated using Curve Expert 1.3 software. Evans blue
content was then calculated based on the concentration
values and presented as ng/mg.
Histopathology
The body of the pancreas was harvested and fixed in 10%
formalin solution over 24 h, embedded in paraffin, sec-
tioned at 4-μm thickness, and stained with hematoxylin
and eosin (H&E). Pathological changes of the pancreas
were observed under an optical microscope.
Scanning electron microscopy
For scanning electron microscopy (SEM), the venules
of rat small intestine mesentery were immediately
removed, cut along their longitudinal axis to open the
lumen, and fixed in 3% glutaraldehyde/1.5% parafor-
maldehyde/0.1 M CBS, pH 7.4. Then all samples were
sequentially fixed in 1% osmium tetroxide solution,
dehydrated with a graded series of ethanol, transferred to
t-butyl alcohol, and freeze dried with a freeze dryer
(ES-2030, Hitachi High-Technologies, Japan). Tissues
were coated with gold palladium particles and examined
using a scanning electron microscope (JSM-6380LV, JEOL
Ltd., Japan).
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Visualization of capillary leakage by tracking
of FITC-albumin
Using fluorescein isothiocyanate (FITC)-albumin as a
plasma marker, capillary leakage of the intestine was
observed visually. Fifteen minutes before the rats were
sacrificed 1 mg/0.5 mL FITC-albumin (Sigma, MO,
USA) was injected into the femoral vein. After 15 min,
the abdomen was opened and the intestinal tissues and
small intestinal mesentery were harvested. The intestinal
tissues were fixed in 4% paraformaldehyde, and embed-
ded in Tissue-Tek OCT compound (Sakura Finetek
USA, Inc.). Frozen sections (10-μm thickness) were cut
at −20 °C with a cryomicrotome (Reichert Jung 2800,
Leica, Germany). The small intestinal mesentery was
placed on glass slides. They were observed under a
confocal microscope and pictures were taken.
Immunohistochemistry staining of AQP1 in the intestine
After being fixed in 4% paraformaldehyde/3% glutaralde-
hyde/0.1 M PBS for 8–24 h, small intestinal tissues were
embedded and sectioned (5-μm thickness). Then the
sections were dewaxed and rehydrated, followed by
removal of endogenous peroxidase by peroxide and
retrieved with citrate antigen. Sections were sequentially
blocked with 5% bovine serum albumin, incubated with
anti-AQP1 primary antibody (1:200; Abcam, Cambridge,
UK) for 2 h at 37 °C, and with secondary antibody
(1:100; Abcam, Cambridge, UK) for 20 min at 37 °C.
Sites of peroxidase activity were visualized with DAB.
Finally, sections were stained with hematoxylin, dehydrated,
and cleared with gradient alcohol and xylene, and mounted
in a neutral mounting medium.
Western blotting
Small intestinal tissue was homogenized on ice and
50 μL of 2 × cell lysis buffer containing protease inhibi-
tors (Cell Signaling, USA) was added to each sample.
Homogenized samples were mixed and incubated on ice.
Next, 50 μL 2 × SDS loading buffer was added. After
proteins were separated in SDS PAGE (12% separating
gel and 3% spacer gel), they were transferred to a PVDF
membrane. The membrane was first incubated with
AQP1 antibody with 1:1000 dilution for 2 h at 25 °C
(mouse anti-rat AQP1 IgG; Santa Cruz Biotechnology,
Inc., USA) and then incubated with secondary antibody
with 1:5000 dilution for 1 h at 25 °C (Abcam, USA),
according to the manufacturer’s instructions. Densito-
metric results were analyzed with Quantity One image-
analysis software (Bio-Rad, Hercules, CA, USA).
Real-time PCR
Total cellular RNAs were extracted from the small intes-
tinal tissues with RNAiso™ Plus (TaKaRa, Japan) accord-
ing to the instruction of the manufacturer. Reverse
transcriptions were done with the ReverTra qPCR RT
kit (FSQ-101; TOYOBO, Japan); the reaction conditions
were 37 °C for 30 min, then 98 °C for 5 min. The 20 μL
of real-time polymerase chain reaction (PCR) reaction
mixture contained 2 μL cDNA, 10 μL SYBR® Premix Ex
Taq™ II (Perfect Real Time, DRR081, TaKaRa), 0.8 μL
PCR forward primer, 0.8 μL PCR reverse primer, 0.4 μL
ROX reference dye (50×), and 6 μL dH2O. The PCR
primers include GAPDH: 5’-TCTTC CAGGA GCGAG
ATCCC-3’/5’-AGTGA TGGCA TGGAC TGTGG
TCAT-3’ (PCR product, 320 bp), and AQP1: 5’-TCACT
TGGCC GAAAT GACCTG-3’/5’-GTCCC ACCCA
GAAAA TCCAG T-3’ (PCR product, 280 bp). The PCR
was run in a real-time PCR instrument (7500; ABI Co.,
USA) at 95 °C for 30 s, followed by incubation at 95 °C
for 5 s and 60 °C for 31 s, for a total of 40 cycles.
Statistical analysis
Data are presented as mean ± SE. A two sample t test
was performed to compare the difference in values be-
tween two groups, and one-way analysis of variance
(ANOVA) with a post-hoc Fisher’s least-significant-
difference test was applied to identify any significant
change of value among several groups. All statistical
assessments were considered significantly different at a
value of p < 0.05. Statistical analyses were performed
using SPSS 15.0 statistics software (SPSS Inc., Chicago,
IL, USA).
Results
Culture, identification, and labeling of MSCs, and tracking
in the small intestine
The MSCs maintained strong proliferative ability and
attached to the wall of the culture vessel. Passage 3 cells
showed a spindle and fibroblast-like shape, and whirl-
like distribution on culture plates (Fig. 1a). The cells
were identified by their surface markers. High expression
of CD 29/90 and low expression of CD 34/45 confirmed
that these cells were MSCs (Fig. 1c–f ). After CM-Dil
labeling, red fluorescence was observed in the cytoplasm
of MSCs (Fig. 1b). Small intestine frozen sections
showed CM-Dil-labeled cells in the mucous layer of the
24-h MSC-treated rats (Fig. 1g–i).
Amylase and albumin of blood and ascites
The ANP rats and the culture media-treated rats had a
large amount of bloody ascites in the abdominal cavity.
After treatment with MSCs, the output of ascites was
decreased significantly at the corresponding time point.
The results showed that the levels of serum amylase in
the ANP group and the culture media-treated group
were higher than the levels in the control group at the
corresponding time point. With MSC treatment, the
levels of serum and ascites amylase were lower than that
Lu et al. Stem Cell Research & Therapy  (2017) 8:12 Page 4 of 13
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of the ANP group and the culture media-treated group
at the corresponding time point. The levels of serum
albumin were negatively time-dependent in the ANP
group and the culture media-treated group, and were
lower than the control group at the corresponding time
points. After treatment with MSCs, the levels of serum
albumin were higher than levels observed in the ANP
group and the culture media-treated group at the
corresponding time points. The levels of ascites albumin
were positively time-dependent in the ANP group and
the culture media-treated group, and were higher than
the levels in the MSC-treated group at the correspond-
ing time points (Table 1).
Histopathology of the pancreas
The ANP model was established successfully. Rats had
visible saponification spots on the omentum and mesen-
tery. Under light microscopy, there were no significant
pathological changes in pancreatic tissues in rats in the
control group. However, the pancreatic damage in the
(See figure on previous page.)
Fig. 1 Characterization of MSCs isolated from rat bone marrow and tracking of infused CM-Dil-labeled MSCs in the small intestine. a Typical cell
morphology of MSCs with adherent growth as spindle-shaped and fibroblast-like, whirl-like distribution at 3 days of the third passage culture (×200). b
MSCs displayed red fluorescence that was evenly labeled with CM-Dil (×200). c–f Expression of surface markers of MSCs by flow cytometry. The surface
markers of c CD29, d CD90, e CD34, and f CD45 were 93.3%, 93.8%, 0.78%, and 1.43%, respectively. g–i In-vivo localization of MSCs in the small
intestine 24 h after the establishment of the rat ANP model; the picture of the rat small intestine frozen section with (g) or without (h) fluorescence.
The merged picture (i) with g and h showed that most of the MSCs localized to the small intestine mucous layer (×100)
Table 1 Results of amylase, albumin, ascites output, and Evans blue assays (n = 10 for each time point)
6 h 12 h 24 h
Control group
Serum amylase (IU/L) 834.10 ± 30.67 824.00 ± 20.50 831.10 ± 29.49
Serum albumin (g/L) 15.80 ± 0.29 15.60 ± 0.27 16.20 ± 0.92
Evans blue (ng/mg) 5.07 ± 0.47 5.62 ± 0.78 4.90 ± 0.56
ANP group
Serum amylase (IU/L) 3831.30 ± 178.52* 6650.90 ± 366.15* 2470.70 ± 126.41*
Serum albumin (g/L) 13.10 ± 0.31* 11.40 ± 0.22* 6.90 ± 0.53*
Evans blue (ng/mg) 13.40 ± 0.97* 21.88 ± 1.19* 39.46 ± 1.48*,**
Ascites outputa (mL) 7.75 ± 0.84 13.35 ± 1.06 21.15 ± 1.69
Ascites albumina (mg) 46.00 ± 5.40 56.00 ± 5.20 88.00 ± 9.50
Ascites amylasea (IU/L) 18,110.90 ± 752.26 33,017.70 ± 4605.52 11,582.70 ± 1040.69
Culture media-treated group
Serum amylase (IU/L) 3898.30 ± 139.81* 6604.80 ± 356.46* 2456.00 ± 106.70*
Serum albumin (g/L) 13.03 ± 0.18* 11.48 ± 0.19* 6.94 ± 0.41*
Evans blue (ng/mg) 13.45 ± 0.16* 22.00 ± 0.53* 40.06 ± 1.27*
Ascites outputa (mL) 7.95 ± 0.84 13.90 ± 0.46 21.00 ± 1.21
Ascites albumina (mg) 45.80 ± 5.01 57.70 ± 1.62 88.90 ± 6.04
Ascites amylasea (IU/L) 18,162.30 ± 584.23 33,064.80 ± 3960.86 11,590.10 ± 317.65
MSC-treated group
Serum amylase (IU/L) 3179.80 ± 217.49***,**** 5241.50 ± 399.00***,**** 2038.30 ± 98.46***,****
Serum albumin (g/L) 13.88 ± 0.12***,**** 12.19 ± 0.19***,**** 9.48 ± 0.80***,****
Evans blue (ng/mg) 11.40 ± 0.77 18.62 ± 0.94***,**** 33.22 ± 1.79***,****
Ascites output (mL) 7.06 ± 0.78 10.31 ± 0.93***,**** 15.80 ± 1.44***,****
Ascites albumin (mg) 41.80 ± 5.40 43.30 ± 2.08***,**** 61.00 ± 7.05***,****
Ascites amylase (IU/L) 15,296.00 ± 920.21***,**** 19,558.00 ± 1627.54***,**** 9097.90 ± 540.51***,****
aThere was no ascites fluid observed in the control group
After induction of acute necrotizing pancreatitis (ANP) and treatment with mesenchymal stem cells (MSCs), serum and ascites were collected at different time
points and assayed for amylase and albumin. Data are shown as mean ± SE
*p < 0.01, versus control group at the same time points; **p < 0.01 versus all other ANP group time points; ***p < 0.05, versus ANP group at the same time points;
****p < 0.05, versus culture media-treated group at the same time points; as tested using a two-sample t test, and one-way ANOVA for comparing several groups
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ANP group was more severe than that in the control
group at the corresponding time points. After treatment
with MSCs, pathological changes were milder than
changes observed in the ANP group (Fig. 2).
Small intestine capillary leakage
Small intestine capillary leakage caused by ANP was
evaluated through the Evans blue leakage assay. The
levels of Evans blue content in intestinal tissues were
positively time-dependent in the ANP and the culture
media-treated groups, and were higher than the control
group at the corresponding time points. After treatment
with MSCs, the levels of Evans blue content in intestinal
tissues were lower than the levels in the ANP group and
the culture media-treated group at the corresponding
time points (Table 1). The small intestine frozen sections
and small intestinal mesentery covered glass slide
showed increased amounts of FITC-albumin which had
leaked out of the capillary in the ANP group compared
to the control group. After treatment with MSCs, the
leakage of FITC-albumin decreased significantly at the
corresponding time points (Fig. 3).
Endothelial gap morphology demonstrated by SEM
The change of the luminal surface of small intestinal
mesentery venules was observed using SEM. The
damage to the connections of venule endothelial cells
increased over time after induction of ANP. The gaps
between connections of endothelial cells progressed at
each time point, and were most noticeable at the 24-h
time point. After treatment with MSCs, the damage
observed was less than that seen in the ANP group at
the corresponding time points (Fig. 4).
AQP1 expression in intestinal tissues
The result of immunohistochemistry (IHC) staining
showed that AQP1 was expressed predominantly on the
plasma membrane of the endothelial cells and the
erythrocytes in the vessel (Fig. 5a). Compared with the
control group, the expression of AQP1 decreased signifi-
cantly at 24 h after induction of ANP (Fig. 5b). After
treatment with MSCs, the expression of AQP1 was
higher than the ANP group at the corresponding time
point using IHC (Fig. 5c) and Western blotting (Fig. 5d
and e), respectively.
Real-time PCR analysis showed that AQP1 mRNA ex-
pression levels in intestinal tissues were negatively time-
dependent in the ANP group and the culture media-
treated group, and were lower than levels observed in
the control group at the corresponding time points.
Compared to the ANP group and the culture media-
treated group, the AQP1 mRNA expression levels were
higher in the MSC-treated group at the corresponding
time points (Table 2).
Discussion
The cascaded release of various inflammatory mediators
and cytokines during the early stages of ANP may dam-
age the capillary endothelial barrier and lead to capillary
leakage. At this time, a lot of intravascular contents leak
into the third space, which may lead to the reduction of
effective circulatory blood volume and the insufficient
end-organ perfusion that could induce multiple organ
dysfunction [28, 29]. Capillary leakage in the lung leads
to interstitial edema and alveolar fluid accumulation,
which is seen during acute lung injury and respiratory
distress syndrome in ANP [29, 30]. Retroperitoneal
edema, fluid collections, ascites, and intestinal edema
occurs in the abdomen during ANP, leading to intra-
abdominal hypertension. This can contribute to insuffi-
cient end-organ perfusion within the cardiovascular,
respiratory, and renal systems [31].
Large volumes of fluid accumulate in the peritoneal
cavity in ANP. Ascites fluid can induce inflammatory
cytokines and enhance the inflammatory response asso-
ciated with severe acute pancreatitis [32, 33], and can
play important roles in the pathologic course of this dis-
ease [34]. The rapid rise in the amount of ascites output
and the levels of amylase and albumin in the blood and
ascites are characteristic, and are usually diagnostic
criteria of acute pancreatitis [35–37]. In our study, we
found an increased amount of ascites, elevated ascitic
albumin, and decreased serum albumin in rats with
ANP over time, indicating that leakage of abdominal
organs gradually increased with disease progression. Gut
permeability was correlated with the severity of acute
pancreatitis [38]. The Evans blue assay and tracking of
FITC-albumin indicated that there was significantly
increased intestinal capillary leakage in the ANP rats
compared with the control group. Gradually increasing
leakage was observed in the ANP rat model at 6 h, 12 h
and 24 h. Using SEM, the damage to the connections of
endothelial cells of venules was increased over time after
induction of ANP. The gaps between connections of
endothelial cells progressed at each time point, and were
most noticeable at the 24-h time point.
AQPs are integral hydrophobic membrane proteins
that could form the water channel and facilitate water
movement across the cell membrane. There are 13
different AQPs in the AQP family that exist in various
tissues [2]. AQP1 was the first member of the AQP
family to be identified in erythrocytes [3]. In the small
intestine, AQP1 is widely distributed on the capillary or
microvascular endothelium of lymphatic cells [4–7].
Studies have shown that abnormalities in AQP1 contrib-
ute to the development of many diseases [2, 6]. The ex-
pression of AQP1 was significantly reduced in a murine
model of LPS-induced acute lung injury, and in the
pancreas, lung, and intestinal tissue of acute necrotizing
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pancreatitis in rats [9]. Our results show that the expres-
sion of AQP1 in the small intestine decreased gradually
over time in ANP, accompanied by a time-dependent
increase in leakage.
The capillary endothelial barrier consists of capillary
endothelial cells, connections between endothelial cells,
and the basement membrane. Any changes in these
three components may lead to changes in capillary per-
meability and leakage. The damage to the connections of
capillary endothelial cells increased over time after the
induction of ANP. The gaps between connections of
endothelial cells caused damage to the intestinal capil-
lary endothelial barrier, resulting in a large amount of
bloody ascites in the abdominal cavity in the ANP group.
AQP1 can mediate inter-cytomembrane water transpor-
tation, resulting in the transport of water extravasated to
interstitial tissue or the abdominal cavity back into the
vessels across the capillary wall. This results in reduced
tissue edema and ascites [3, 39, 40]. The expression of
AQP1 decreased significantly after induction of ANP.
Fig. 3 Tracking of infused FITC-albumin in the small intestine and the mesentery of the small intestine 24 h after the establishment of the rat
ANP model. a–c Small intestine frozen sections (×50). FITC-albumin located in the small intestinal capillaries in the control group (a). Compared
to the control group, a lot of extravasated FITC-albumin was seen in the intestinal tissues in the ANP group (b). After treatment with MSCs,
extravasation of the FITC-albumin was less than that in the ANP group (c). d–f Small intestinal mesentery covered glass slide (×50). FITC-albumin
located in the small intestine mesentery capillaries in the control group (d). High levels of FITC-albumin were observed in the areas of perivascular
space in the ANP group (e). Extravasation of the FITC-albumin was reduced significantly in the MSC-treated group (f)
(See figure on previous page.)
Fig. 2 Histopathology of the pancreas. a–gH&E staining of rat pancreas (×100). There were no significant pathological changes in pancreatic tissues in
the control group (a). The pancreas exhibited mild interstitial edema and a few inflammatory cells infiltrated in the acute necrotizing pancreatitis (ANP)
group at 6 h (b). Compared to the ANP group at 12 h (d), the edema formation, hemorrhage, inflammatory cell infiltration, and necrosis was more
severe in the ANP group at 24 h (f). Pancreatic damage was reduced significantly in the mesenchymal stem cells (MSCs)-treated group at the 6-h, 12-h,
and 24-h time points (c, e, and g). h The pancreatic histopathologic score of each group is shown as the mean ± SE (n = 10). *p < 0.01, versus the
control group at the same time point; +p < 0.05, #p < 0.01, versus the ANP group at the same time point; as tested using a two-sample t test for
comparing between two groups, and one-way ANOVA for comparing several groups
Lu et al. Stem Cell Research & Therapy  (2017) 8:12 Page 9 of 13
This induced edema within the small intestine, resulting
in the impairment of small intestinal microcirculation
and injury to the small intestine in ANP.
Studies have shown that MSCs have strong differenti-
ation potential. There are few ethical issues with their
use. Additionally, they are easy to access, have weak
immunogenicity, and are able to regulate the immune
system and regenerate damaged tissue. Taken together,
MSCs are good candidates for cell-based therapy [13,
41]. MSCs could repair injured alveolar epithelium in-
duced by LPS in mice [42] and reduced lung histologic
damage in septic mice [43]. The results of pancreatic
pathological damage are consistent with prior research
[14]. MSCs could reduce inflammation and damage to
pancreatic tissue in the rat model of acute pancreatitis.
MSC treatment resulted in faster recovery to the struc-
ture and function of the small intestine in the mouse
model of radiation-induced gastrointestinal tract damage
[15, 23]. MSCs could differentiate into vascular endothe-
lial cells and improve cardiac function in a rat model of
dilated cardiomyopathy [11, 44, 45].
Three different MSC delivery routes (intravenous,
intraperitoneal, and anal injection) were used in the
studies of intestinal disease [15, 23, 24, 46–48]. For the
reasons that follow, MSCs were transplanted via tail vein
injection in this study. 1) Anal injections are usually
used to study large intestinal diseases [49]. 2) The intra-
venous injection is historically the most common
method for MSC delivery [15, 17, 23, 24, 47, 48, 50] and
was identified to be better in comparison with
Fig. 4 Scanning electron microscopy of endothelium in venules of rat small intestine mesentery. a The luminal surface of the small intestine
mesentery venules was smooth and flat in the control group. b–d The damage to the connections of venule endothelial cells increased over
time after induction of ANP (b, ANP 6 h; c, ANP 12 h; d, ANP 24 h). The gaps between connections of endothelial cells at 24 h was the most
wide of all time points (d). e–f After treatment with MSCs, the damage was less than that observed in the ANP group at the corresponding time
points (e, MSC-treated 12 h; f, MSC-treated 24 h). The arrows refer to the connections of venule endothelial cells
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intraperitoneal injection [51]. 3) Large volumes of ascites
fluid accumulate in the peritoneal cavity in ANP. 4) The
complications associated with intraperitoneal injection
are a concern. These complications include that stem
cells may irritate the peritoneal lining causing peritonitis
[52] and physical damage to intra-abdominal structures,
such as vaginal vault perforation, bladder erosion, and
bowel perforation [53]. 5) Structural changes to the
Fig. 5 Intestinal aquaporin 1 (AQP1) expression. a–d Immunohistochemistry of AQP1 (×100). There was high expression of AQP1 on the plasma
membrane of the endothelial cells in the intestinal capillary in the control group (a). Compared with the control group, the expression of AQP1
decreased significantly in the acute necrotizing pancreatitis (ANP) group at 24 h (b). After treatment with mesenchymal stem cells (MSCs), the
expression of AQP1 was higher than the expression in the ANP group at 24 h (c). Compared with the ANP group at 24 h, the expression of AQP1
was not significantly changed after treatment with culture media (d). e, f Western blotting of AQP1 protein in the small intestine. Values are
presented as the mean ± SE (n = 10). *p < 0.01, versus the control group at 24 h and all ANP group time points; #p < 0.05, versus the ANP group at
the same time point; ☆p < 0.05, versus the culture media-treated group at 24 h; as tested using a two-sample t test for comparing between two
groups, and one-way ANOVA for comparing several groups
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capillary endothelial barrier are one of the objectives in
this study. MSCs that are injected intravenously may be
more effective for the repair of damaged capillary endo-
thelial cells.
Similar to previous studies [15, 23, 24], MSCs might
reside in the small intestine. In this study the amount of
CM-Dil-labeled MSCs was observed under a confocal
microscope. After the treatment with MSCs, the serum
amylase, ascitic amylase, ascites output, and ascitic albu-
min were decreased significantly, and the serum albumin
was increased. We found that the level of small intestinal
capillary leakage was alleviated, and the damage to the
pancreas and small intestine was ameliorated. Further-
more, the expression of small intestinal AQP1 was en-
hanced after MSC therapy. These parameters were not
significantly altered after treatment with culture media,
excluding culture medium as a factor in the MSC-
treated group. The MSCs may exert their therapeutic ef-
fects on differentiation and replacement of the damaged
capillary endothelial cells. Alternatively, they may influ-
ence cell-to-cell contact, or interact with immune cells
[46], diminishing the various inflammatory mediators
and cytokines which are normally released during ANP.
Conclusions
The damage to the intestinal capillary endothelial barrier
and the dysfunction of AQP1 could lead to capillary
leakage in ANP. MSCs could decrease small intestinal
capillary leakage and microcirculation disorder by
diminishing the damage to the capillary endothelial bar-
rier and reversing the decease of AQP1 expression in
the small intestine. MSCs lessen small intestinal injury
in rats with ANP.
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